Schrick, Austria

Manfred Schuster

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 32(Granted Patents)


Location History:

  • Schrick, AT (2010 - 2019)
  • Vienna, AT (2017 - 2022)

Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Manfred Schuster: Innovator in Cancer Treatment and Biotech

Introduction

Manfred Schuster is a prominent inventor based in Schrick, Austria. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. With a total of 17 patents to his name, Schuster's work has the potential to impact the lives of many patients.

Latest Patents

Among his latest patents is a method for treating GD2 positive cancer. This innovative approach involves administering a preparation comprising an anti-GD2 antibody to a patient as a continuous intravenous infusion over 24 hours per day. Another notable patent focuses on the measurement of peptidic degradation products of a proteolytic cascade in blood samples. This invention discloses a method for measuring these degradation products in biological samples, especially blood samples, by incubating the sample until a steady state equilibrium is reached.

Career Highlights

Throughout his career, Schuster has worked with several notable companies, including Apeiron Biologics AG and Greenovation Biotech GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the biotech sector.

Collaborations

Some of his notable coworkers include Hans Loibner and Evelyne Janzek-Hawlat. Their collaboration has contributed to the advancement of research and development in the field.

Conclusion

Manfred Schuster's contributions to biotechnology and cancer treatment through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…